DiaSorin SpA Valuation

34D Stock  EUR 104.05  0.95  0.90%   
At this time, the firm appears to be fairly valued. DiaSorin SpA shows a prevailing Real Value of €104.34 per share. The current price of the firm is €104.05. Our model computes the value of DiaSorin SpA from reviewing the firm fundamentals such as Profit Margin of 0.20 %, current valuation of 8.48 B, and Operating Margin of 0.29 % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
104.05
Please note that DiaSorin SpA's price fluctuation is very steady at this time. Calculation of the real value of DiaSorin SpA is based on 3 months time horizon. Increasing DiaSorin SpA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the DiaSorin stock is determined by what a typical buyer is willing to pay for full or partial control of DiaSorin SpA. Since DiaSorin SpA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DiaSorin Stock. However, DiaSorin SpA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  104.05 Real  104.34 Hype  104.05 Naive  101.7
The real value of DiaSorin Stock, also known as its intrinsic value, is the underlying worth of DiaSorin SpA Company, which is reflected in its stock price. It is based on DiaSorin SpA's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of DiaSorin SpA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
102.62
Downside
104.34
Real Value
106.06
Upside
Estimating the potential upside or downside of DiaSorin SpA helps investors to forecast how DiaSorin stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DiaSorin SpA more accurately as focusing exclusively on DiaSorin SpA's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
103.47104.37105.26
Details
Hype
Prediction
LowEstimatedHigh
102.33104.05105.77
Details
Naive
Forecast
LowNext ValueHigh
99.98101.70103.43
Details

DiaSorin SpA Total Value Analysis

DiaSorin SpA is presently estimated to have takeover price of 8.48 B with market capitalization of 6.1 B, debt of 1.23 B, and cash on hands of 78.3 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the DiaSorin SpA fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
8.48 B
6.1 B
1.23 B
78.3 M

DiaSorin SpA Investor Information

About 58.0% of the company shares are owned by insiders or employees . The book value of DiaSorin SpA was presently reported as 30.1. The company last dividend was issued on the 23rd of May 2022. Based on the key measurements obtained from DiaSorin SpA's financial statements, DiaSorin SpA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.

DiaSorin SpA Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DiaSorin SpA has an asset utilization ratio of 38.3 percent. This implies that the Company is making €0.38 for each dollar of assets. An increasing asset utilization means that DiaSorin SpA is more efficient with each dollar of assets it utilizes for everyday operations.

DiaSorin SpA Ownership Allocation

DiaSorin SpA holds a total of 53.84 Million outstanding shares. DiaSorin SpA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

DiaSorin SpA Profitability Analysis

The company reported the revenue of 1.24 B. Net Income was 310.97 M with profit before overhead, payroll, taxes, and interest of 824.77 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates DiaSorin SpA's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in DiaSorin SpA and how it compares across the competition.

About DiaSorin SpA Valuation

The stock valuation mechanism determines DiaSorin SpA's current worth on a weekly basis. Our valuation model uses a comparative analysis of DiaSorin SpA. We calculate exposure to DiaSorin SpA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DiaSorin SpA's related companies.
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics tests for private and hospital analysis laboratories worldwide. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy. DIASORIN S operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1928 people.

8 Steps to conduct DiaSorin SpA's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DiaSorin SpA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DiaSorin SpA's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain DiaSorin SpA's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine DiaSorin SpA's revenue streams: Identify DiaSorin SpA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research DiaSorin SpA's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish DiaSorin SpA's growth potential: Evaluate DiaSorin SpA's management, business model, and growth potential.
  • Determine DiaSorin SpA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DiaSorin SpA's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for DiaSorin Stock analysis

When running DiaSorin SpA's price analysis, check to measure DiaSorin SpA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaSorin SpA is operating at the current time. Most of DiaSorin SpA's value examination focuses on studying past and present price action to predict the probability of DiaSorin SpA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaSorin SpA's price. Additionally, you may evaluate how the addition of DiaSorin SpA to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals